Skip to content
← Full study record

NCT00577278 · MORE INFO

Limitations, agreements, and source contact

A Phase II Study of Allo-HCT for B-Cell NHL Using Zevalin, Fludarabine and Melphalan · Source last updated 2024-02-16

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
true
point Of Contact
email
mamei@coh.org
organization
City of Hope Medical Center
phone
626-359-8111
title
Dr. Matthew Mei
Complete source fields
certain Agreement
pi Sponsor Employee
true
point Of Contact
email
mamei@coh.org
organization
City of Hope Medical Center
phone
626-359-8111
title
Dr. Matthew Mei

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice